108
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Immunomodulatory activities and subacute toxicity of a novel β-glucan from Paenibacillus polymyxa JB115 in rats

, , , , , , , , & show all
Pages 124-134 | Received 07 Apr 2010, Accepted 16 Apr 2010, Published online: 26 May 2010

References

  • Ross, G.D., Vetvicka, V., Yan, J., Xia, Y., Vetvicková, J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology 1999, 42, 61–74.
  • Lee, K.Y., Lee, M.H., Chang, I.Y., Yoon, S.P., Lim, D.Y., Jeon, Y.J. Macrophage activation by polysaccharide fraction isolated from Salicornia herbacea. J. Ethnopharmacol. 2006, 103, 372–8.
  • Wang, Z., Luo, D. Antioxdant activities of different fractions of polysaccharide purified from Gynostemma pentaphyllum Makino. Carbohyd Polym. 2007, 68, 54–58.
  • Kim, M.K., Lee, I.Y., Ko, J.H., Rhee, Y.H., Park, Y.H. Higher intracellular levels of uridinemonophosphate under nitrogen-limited conditions enhance metabolic flux of curdlan synthesis in Agrobacterium species. Biotechnol. Bioeng. 1999, 62, 317–23.
  • Ko, Y.T., Lin, Y.L. 1,3-beta-glucan quantification by a fluorescence microassay and analysis of its distribution in foods. J. Agric. Food Chem. 2004, 52, 3313–8.
  • Babícek, K., Cechová, I., Simon, R.R., Harwood, M., Cox, D.J. Toxicological assessment of a particulate yeast (1,3/1,6)-beta-D-glucan in rats. Food Chem. Toxicol. 2007, 45, 1719–30.
  • Bohn, J.A., BeMiller, J.N. (1→3)-Beta-d-glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym. 1995, 28, 3–14.
  • Brown, G.D., Gordon, S. Immune recognition of fungal beta-glucans. Cell. Microbiol. 2005, 7, 471–9.
  • Chihara, G., Maeda, Y., Hamuro, J., Sasaki, T., Fukuoka, F. Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) sing. Nature 1969, 222, 687–8.
  • Di Luzio, N. R., McNamee, R., Jones, E., Cook, J. A., Hoffman, E. O. The employment of glucan and glucan activated macrophages in the enhancement of host resistance to malignancies in experimental animals. In M.D. Fink ed. The Macrophage in Neoplasia. Academic Press, New York. 1976, 181–198.
  • Ohno, N., Suzuki, I., Oikawa, S., Sato, K., Miyazaki, T., Yadomae, T. Antitumor activity and structural characterization of glucans extracted from cultured fruit bodies of Grifola frondosa. Chem. Pharm. Bull. 1984, 32, 1142–51.
  • Seljelid, R. A water-soluble aminated ß1–3-D-glucan derivative causes regression of solid tumors in mice. Biosci. Rep. 1986, 6, 845.
  • Kitamura, S., Hori, T., Kurita, K., Takeo, K., Hara, C., Itoh, W., Tabata, K., Elgsaeter, A., Stokke, B.T. An antitumor, branched (1–>3)-beta-D-glucan from a water extract of fruiting bodies of Cryptoporus volvatus. Carbohydr. Res. 1994, 263, 111–21.
  • Wakui, A., Kasai, M., Konno, K., Abe, R., Kanamaru, R., Takahashi, K., Nakai, Y., Yoshida, Y., Koie, H., Masuda, H. [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group]. Gan To Kagaku Ryoho. 1986, 13, 1050–9.
  • Tanabe, H., Imai, N., Takechi, K. Studies on usefulness of postoperative adjuvant chemotherapy with lentinan in patients with gastrointestinal cancer. J. Jpn. Soc. Cancer Ther. 1990, 25, 1657.
  • Matsuoka, H., Seo, Y., Wakasugi, H., Saito, T., Tomoda, H. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res. 1997, 17, 2751–5.
  • Fujimoto, S. [Clinical efficacies of schizophyllan (SPG) on advanced gastric cancer]. Nippon Geka Gakkai Zasshi 1989, 90, 1447–50.
  • Kimura, Y., Tojima, H., Fukase, S., Takeda, K. Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. Acta Otolaryngol. Suppl. 1994, 511, 192–5.
  • Nakano, T., Oka, K., Hanba, K., Morita, S. Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer. Clin. Immunol. Immunopathol. 1996, 79, 79–86.
  • Morikawa, K., Takeda, R., Yamazaki, M., Mizuno, D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells. Cancer Res. 1985, 45, 1496–501.
  • Scaringi, L., Marconi, P., Boccanera, M., Tissi, L., Bistoni, F., Cassone, A. Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. J. Gen. Microbiol. 1988, 134, 1265–74.
  • Johanssona, L., Tuomainena, P., Anttilab, H., Ritac, H., Virkki, L. Effect of processing on the extractability of oat beta-glucan. Food Chemistry. 2007, 150, 1439–1445.
  • Kernodle, D.S., Gates, H., Kaiser, A.B. Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection. Antimicrob. Agents Chemother. 1998, 42, 545–9.
  • Rylander, R., Fogelmark, B., McWilliam, A., Currie, A. (1–>3)-beta-D-glucan may contribute to pollen sensitivity. Clin. Exp. Immunol. 1999, 115, 383–4.
  • Rylander, R., Lin, R.H. (1–>3)-beta-D-glucan - relationship to indoor air-related symptoms, allergy and asthma. Toxicology 2000, 152, 47–52.
  • Ikeda, Y., Sunakawa, T., Okamoto, K., Hirayama, A. [Toxicological studies on sophorolipid derivatives. (II). Subacute toxicity study of polyoxypropylene (12) [2′-0-beta-D-glucopyranosyl-beta-D-glucopyranosyl] oxy-] fatty acid ester-]. J. Toxicol. Sci. 1986, 11, 213–24.
  • Williams, D.L., Sherwood, E.R., Browder, I.W., McNamee, R.B., Jones, E.L., Di Luzio, N.R. Pre-clinical safety evaluation of soluble glucan. Int. J. Immunopharmacol. 1988, 10, 405–14.
  • Ishii, H., Usami, S., Fujimoto, T., Moriyuki, H., Hashimoto, S., Ichimura, M. [Subacute toxicity study of lentinan in rats. 5-week intravenous treatment (author’s transl)]. J. Toxicol. Sci. 1980, 5 Suppl, 11–31.
  • Iwamoto, N., Yoshioka, T., Nitta, K., Ito, K. Glomerular endothelial injury associated with free radical production induced by a fungal cell wall component, (1–>3) beta-D glucan. Life Sci. 1998, 62, 247–55.
  • Fogelmark, B., Sjöstrand, M., Rylander, R. Pulmonary inflammation induced by repeated inhalations of beta(1,3)-D-glucan and endotoxin. Int. J. Exp. Pathol. 1994, 75, 85–90.
  • Fogelmark, B., Goto, H., Yuasa, K., Marchat, B., Rylander, R. Acute pulmonary toxicity of inhaled beta-1,3-glucan and endotoxin. Agents Actions 1992, 35, 50–6.
  • Takahashi, H., Ohno, N., Adachi, Y., Yadomae, T. Association of immunological disorders in lethal side effect of NSAIDs on beta-glucan-administered mice. FEMS Immunol. Med. Microbiol. 2001, 31, 1–14.
  • Shimazu, H., Takeda, K., Onodera, C., Makita, I., Hashi, T., Yamazoe, T., Kokuba, Y., Tanigawa, H., Ohkuma, S., Shinpo, K., Takeuchi, M. [Intravenous chronic toxicity of lentinan in rats: 6-month treatment and 3-month recovery (author’s transl)]. J. Toxicol. Sci. 1980, 5 Suppl, 33–57.
  • Chesterman, H., Heywood, R., Allen, T.R., Street, A.E., Edmondson, N.A., Prentice, D.E. The intravenous toxicity of lentinan to the beagle dog. Toxicol. Lett. 1981, 9, 87–90.
  • Sortwell, R.J., Dawe, S., Allen, D.G., Street, A.E., Heywood, R., Edmondson, N.A., Gopinath, C. Chronic intravenous administration of lentinan to the rhesus monkey. Toxicol. Lett. 1981, 9, 81–5.
  • Sakurai, T., Ohno, N., Yadomae, T. Changes in immune mediators in mouse lung produced by administration of soluble (1–>3)-beta-D-glucan. Biol. Pharm. Bull. 1994, 17, 617–22.
  • Kata, H., Inoue, M., Mukai, S., Kawahito, Y., Yoshida, T., Asai, K., Kimura, S., Hashiramoto, A., Yamamura, Y., Sano, H., Sugino, S., Kondo, M. Morphological study of cytotoxicity produced by PSK-induced polymorphonuclear leukocytes (PMNs) and Nocardia rubra cell wall skeleton. Biotherapy 1996, 9, 229–39.
  • Delaney, B., Carlson, T., Zheng, G.H., Hess, R., Knutson, N., Frazer, S., Ostergren, K., van Zijverden, M., Knippels, L., Jonker, D., Penninks, A. Repeated dose oral toxicological evaluation of concentrated barley beta-glucan in CD-1 mice including a recovery phase. Food Chem. Toxicol. 2003, 41, 1089–102.
  • Spicer, E.J., Goldenthal, E.I., Ikeda, T. A toxicological assessment of curdlan. Food Chem. Toxicol. 1999, 37, 455–79.
  • Jung, H.K., Hong, J.H., Park, S.C., Park, B.K., Nam, D.H., Kim, S.D. Production and physicochemical characterization of beta-glucan produced by Panebacillus polymyxa JB115. Biotechnol Bioprocess Eng. 2007, 12, 713–719.
  • Jung, H.K., Kang, E.H., Chang, Z.Q., Hong, J.H., Kim, S.D., Park, B.K., Yun, H.I., Park, S.C. Pathogenicity of Paenibacillus polymyxa JB115 and single-dose toxicity of its culture broth containing β-glucan in rats. Korean J Vet Res. 2007, 47, 379–387.
  • Delaney, B., Carlson, T., Frazer, S., Zheng, T., Hess, R., Ostergren, K., Kierzek, K., Haworth, J., Knutson, N., Junker, K., Jonker, D. Evaluation of the toxicity of concentrated barley beta-glucan in a 28-day feeding study in Wistar rats. Food Chem. Toxicol. 2003, 41, 477–87.
  • Hall, R.L., Everds, N.E. Principles of clinical pathology for toxicology studies. In: Hayes AW, Principles and Methods of Toxicology, fifth edition. CRC Press, Boca Raton. 2008, pp. 1317–1358.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.